The Association of Serum Anti-Lysosomal-Associated Membrane Protein-2 Antibody with Vasculitis Combined with Hypertension

Figure 3

The levels of serum anti-LAMP-2 antibody in different groups. (a) In VAS-HTN patients and HC. (b) In VAS-HTN patients with the active stage and inactive stage. (c) In VAS-HTN patients with renal injury and non-renal injury. (d) In VAS-HTN subsets.

(a)

(b)

(c)

(d)